Israeli drug prevents 100% of COVID patients from deteriorating in trial

All 18 COVID-19 patients hospitalized with moderate or severe symptoms who received the drug Amor-18 developed by Israeli biotech company Amorphical recovered and were discharged in a few days, the company announced on Wednesday. Of the 19 individuals who were given a placebo, six had to be transferred to intensive care, and two died.

Israel To Have 4th COVID Jab As Europe Struggles

Israel says it plans to become the first nation to introduce a fourth dose of the COVID-19 vaccine as the new Omicron variant already overwhelms hospitals in several countries.

Worthy Christian News